• Discovery of carp, Cyprinus carpio, in the already stressed fishery of Lake Naivasha, Kenya more
  • Discovery of Flabellia petiolata (Halimedaceae, Chlorophyta) in the southern British Isles: A relict population or a new introduction? more
  • Discovery of the parasite Marteilia cocosarum sp. nov. In common cockle (Cerastoderma edule) fisheries in Wales, UK and its comparison with Marteilia cochillia more
  • Discrete Multi-Tone Digital Subscriber Loop Performance in the Face of Impulsive Noise more
  • Discretionary corporate social responsibility: Introducing the GREENER VENUE more
  • Discretization of functionally based heterogeneous objects more
  • Discriminating Thatcherised from typical faces in a case of prosopagnosia more
  • Discriminatory Brain Processes of Native and Foreign Language in Children with and without Reading Difficulties more
  • Discursive equality and everyday talk online: The impact of "superparticipants" more
  • Discursive networks on Facebook during the 2012 French presidential election more
  • Discussant, session on 'Challenges and Advances in the Archaeology and Palaeoanthropology of Non-Modern Humans' more
  • Discussing the global need to rethink ageing and how to ensure a good quality of health and wellbeing in later life more
  • Discussion - Period 1: Neolithic and Bronze Age more
  • Discussion of citizen behavioural change using the nudge effect: a perspective based on social policy interventions more
  • Discussion of citizen behavioural change using the nudge effect: a perspective based on social policy interventions more
  • Discussion of digital gaming’s impact on players’ well-being during the COVID-19 more
  • Discussion of how the Codes of Practice might contribute to improved completion rates more
  • Discussion: early prehistory more
  • Discussion: Experimental wear modelling of lifeboat slipway launches more
  • DISEASE ASSESSMENT WITH THE POLYMERASE CHAIN-REACTION (PCR) IN FOLLICULAR SMALL CLEAVED CELL LYMPHOMA more
  • Disease-free (DFS) and overall survival (OS) at 3.4 years (yrs) for neoadjuvant bevacizumab (Bev) added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide (D-FEC), for women with HER2 negative early breast cancer: The ARTemis trial. more
  • Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis trial more
  • Disembodiment and The Heart: Podcasting as a Safe Space for the Discussion of Intimate Embodied Experience more
  • Disengagement and social support moderate distress among women with a family history of breast cancer more
  • Disentangling Intellectual Property Law Post-Brexit-- Brexit will have a profound effect on trademark and design law in the United Kingdom more

Previous Next